Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Contract Award

18 Dec 2017 07:00

RNS Number : 5632Z
Babcock International Group PLC
18 December 2017
 

18 December 2017

 

Babcock International Group PLC (Babcock or the Group)

Cavendish Nuclear awarded contract to supply Sellafield

 

Babcock subsidiary Cavendish Nuclear, the UK's largest nuclear services business, has been awarded a 10-year contract to supply Sellafield Ltd with specialist handling and containment systems to process nuclear material.

 

Worth up to £95 million over the first three years, Cavendish Nuclear will meet all of Sellafield's requirements for the design, manufacture and supply of this complex bespoke equipment for the treatment and management of nuclear materials.

 

Virtual reality simulation will play a key part in delivering the contract. Once the preliminary design is complete, full-scale mock-ups with virtual reality headsets will allow the customer to test out the ergonomics and identify any modifications at the earliest possible stage.

 

Cavendish Nuclear specialises in the design, manufacture and delivery of services across the nuclear lifecycle and has extensive experience of working across Sellafield, including ongoing work on the design of remote-handling equipment for the product and residues treatment plant.

 

Cavendish Nuclear will use Babcock's Rosyth Dockyard, one of the UK's largest manufacturing facilities, for the project. Following recent major investment in new workshops, fabrication bays and remote overhead cranes, Rosyth has a proven track record of delivering large-scale complex products, including the containment doors for the pile fuel cladding silo at Sellafield.

 

Cavendish Nuclear and its partners will be supported by a supply chain located across the UK, bringing together the best of Britain's nuclear expertise in an integrated team committed to meeting the customer's demanding specification.

 

Babcock CEO Archie Bethel said:

 

"We are delighted that Cavendish Nuclear continues to support Sellafield in the delivery of this strategically important programme. The team will provide the significant manufacturing capacity the project needs, as well as opportunities to share best practice across the UK."

 

 

Ends

 

 

 

Enquiries

 

Babcock International Group PLC

020 7355 5300

Franco Martinelli

Kate Hill

FTI Consulting

020 3727 1340

Andrew Lorenz

Nick Hasell

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFFAFMIFWSELE
Date   Source Headline
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202511:36 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:02 pmRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20255:00 pmRNSNotice of AGM
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20256:27 pmRNSLaunch of Share Buyback Programme
7th Jul 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jul 20253:57 pmRNSDirector/PDMR Shareholding
1st Jul 20255:41 pmRNSFinal Results
25th Jun 20257:00 amRNSPreliminary results for the year ended 31.03.2025
17th Jun 20253:30 pmRNSHolding(s) in Company
10th Jun 20251:11 pmRNSHolding(s) in Company
9th Jun 20254:23 pmRNSDirector Announcement
5th Jun 20259:00 amRNSDirectorate Change
20th May 202512:48 pmRNSBabcock host Cavendish Nuclear teach-in event
23rd Apr 20257:00 amRNSFY25 Post-close Trading Update
26th Mar 20257:30 amRNSBabcock awarded five-year British Army contract
19th Mar 20256:00 pmRNSHargreaves Lansdown
7th Feb 20253:16 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSQ3 trading update and upgrade of FY25 expectations
30th Jan 20254:05 pmRNSHolding(s) in Company
21st Jan 20253:55 pmRNSDirector/PDMR Shareholding
27th Nov 202411:37 amRNSDirector/PDMR Shareholding
18th Nov 20243:06 pmRNSDirector/PDMR Shareholding
18th Nov 20242:34 pmRNSChange of Record Date for Interim Dividend
14th Nov 20244:33 pmRNSDirector/PDMR Shareholding
14th Nov 202411:50 amRNSDirector announcement
13th Nov 20247:00 amRNSResults for the six months ended 30 September 2024
4th Oct 20242:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20244:13 pmRNSDirector/PDMR Shareholding
1st Oct 20243:04 pmRNSHolding(s) in Company
30th Sep 20243:41 pmRNSDirector/PDMR Shareholding
26th Sep 20242:49 pmRNSDirector/PDMR Shareholding
19th Sep 20243:35 pmRNSResult of AGM
19th Sep 20247:00 amRNSAGM trading update
6th Sep 202411:48 amRNSDirector/PDMR Shareholding
29th Aug 20244:33 pmRNSDirector/PDMR Shareholding - Replacement
29th Aug 20241:26 pmRNSDirector/PDMR Shareholding
15th Aug 20241:01 pmRNSNotice of AGM
7th Aug 20249:44 amRNSDirector/PDMR Shareholding
6th Aug 202411:28 amRNSDirector/PDMR Shareholding
5th Aug 20244:26 pmRNSDirector/PDMR Shareholding
2nd Aug 202412:02 pmRNSDirector/PDMR Shareholding
1st Aug 20243:48 pmRNSDirector/PDMR Shareholding
30th Jul 20249:53 amRNSAnnual Financial Report
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.